According to court documents, at least 150 lawsuits involving Byetta and other incretin mimetics have been filed in the multidistrict litigation underway in the Southern District of California. All of the Byetta lawsuits pending in the proceeding allege that the manufacturer of the drug failed to warn doctors and patients about its dangerous pancreatic side effects.Patients who have used Byetta and who went on to develop pancreatic cancer, pancreatitis, or thyroid cancer may be entitled to compensation for their injury-related damages. To learn more about filing a Byetta lawsuit, please visit Bernstein Liebhard LLP's website, or call one of the Firm's attorneys today for a free case review at (888) 340-4807.
Byetta Lawsuit News: Bernstein Liebhard LLP Notes Approval Of Master Complaint In Federal Byetta Pancreatic Cancer Litigation
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts